Megan Cole, Diana Zuckerman, PhD, Brandel France de Bravo, MPH, and Janet A. Phoenix, MD, MPH, Cindy Min, MPH, National Center for Health Research What is HPV? The human papillomavirus virus, also known as HPV, is the most common sexually transmitted infection in the U.S. and around the world. In fact, approximately 20 million Americans […]
Read More »Tag: hpv
The HPV Vaccine
Megan Cole, Diana Zuckerman, PhD, Brandel France de Bravo, MPH, and Janet A. Phoenix, MD, MPH, Cindy Min, MPH, National Center for Health Research What is a HPV Vaccine? The human papillomavirus virus, also known as HPV, is the most common sexually transmitted infection in the world. It can cause various different type of cancer […]
Read More »NCHR Testimony on the Evaluation for High-Risk HPV Detection Devices
March 8, 2019. NCHR testified on March 8th, 2019 at the Microbiology Advisory Committee urging panel members to consider increasing the screening age from 25 to 30.
Read More »NCHR Comments on the USPSTF’s Draft Recommendation Statement, Evidence Review, and Modeling Report on Cervical Cancer Screening
October 9, 2017. The USPSTF proposes new cervical cancer screening recommendations. Surprisingly, the USPSTF proposes eliminating co-testing (pap and HPV test together) as a preferred screening approach in favor of the HPV test alone. Do the proposed recommendations deserve an “A” rating? Read our comments to find out.
Read More »Comments of the Patient, Consumer, and Public Health Coalition on the Proposed Vaccine Information Materials for HPV (Human Papillomavirus) Gardasil®-9 Vaccine
December 21, 2015. It is important that the statement concisely describe the benefits and risks associated with the vaccine. But it is equally important that the statement provide all the essential information about the vaccine.
Read More »